Results 141 to 150 of about 110,820 (315)

Women who take pap smear in Fortaleza - social and sexual characterization.

open access: yesOnline Brazilian Journal of Nursing, 2009
<p class="MsoNormal" style="margin: 0cm 2.25pt 0pt 0cm; line-height: 150%;"><span style="font-size: 10pt; line-height: 150%; font-family: " lang="EN-US">Considering the epidemiological relevance and the mortality of Uterine Cervix Cancer, the
Camila Félix Américo   +6 more
doaj  

Incidence and temporal trends of depression and anxiety following cancer diagnosis in Japan: Insights from the LIFE study

open access: yesInternational Journal of Cancer, Volume 158, Issue 3, Page 621-632, 1 February 2026.
What's new? Depression and anxiety are common but often under‐recognized among cancer patients. Using claims data from 14 municipalities in Japan, this study clarified the incidence and temporal trends of these conditions following cancer diagnosis over a 24‐month follow‐up period.
Kengo Kawaguchi   +5 more
wiley   +1 more source

Mechanisms of enhancer‐driven oncogene activation

open access: yesInternational Journal of Cancer, Volume 158, Issue 2, Page 333-341, 15 January 2026.
Abstract An aggressive subtype of acute myeloid leukemia (AML) is caused by enhancer hijacking resulting in MECOM overexpression. Several chromosomal rearrangements can lead to this: the most common (inv(3)/t(3;3)) results in a hijacked GATA2 enhancer, and there are several atypical MECOM rearrangements involving enhancers from other hematopoietic ...
Joyce Vriend   +2 more
wiley   +1 more source

Trends in cervical cancer incidence in the Netherlands: A join‐point and age–period–cohort analysis (1989–2023)

open access: yesInternational Journal of Cancer, Volume 158, Issue 1, Page 39-44, 1 January 2026.
What's new? This ecological study of trends in cervical cancer incidence from 1989 to 2023 in the Netherlands indicates a positive impact of screening, with a steady decline over the years. However, incidence increased from 2003 to 2023, particularly among younger cohorts, aligning with reduced participation and the introduction of more sensitive, high‐
Kelly Melisa Castañeda   +5 more
wiley   +1 more source

Rare gynecological entity: malignant cervical PEComa (perivascular epithelioid cell differentiation tumour) - challenges in diagnosis, treatment and surveillance

open access: yesBrazilian Journal of Oncology
Perivascular epithelioid cell tumors constitute a family of mesenchymal tumors characterized by the concomitant expression of melanocytic and muscular markers.
Amanda da Silva Anjos   +5 more
doaj   +1 more source

Pelvic lymph node dissection in the treatment of cervical and uterine neoplasms – correlation with the histologic type and disease stage

open access: diamond, 2021
Virgiliu Mihail Prunoiu   +6 more
openalex   +1 more source

Ectopic Prostate Tissue in the Bladder Exhibiting Fluorescence on Photodynamic Diagnosis: A Report of Two Cases

open access: yesIJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction We report two cases of ectopic prostate tissue exhibiting fluorescence during photodynamic diagnosis using 5‐aminolevulinic acid. Case Presentation The first case involved a 57‐year‐old man with a 9‐mm papillary tumor on the right side of the bladder neck.
Michinori Shimizu   +11 more
wiley   +1 more source

Cervical Hemangioma: A case report

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2003
Hemangiomas are benign tumors, which considered being in distance between hamartomas and true neoplasms. Most of the hemangiomas arise in head and neck region and the others grow is trunk and extremities. Hemangiomas of the uterine cervix are rare.
R.Azarhoush (M.D)   +1 more
doaj  

SATB2 is Rarely Expressed in Endometrial or Endocervical Carcinoma. [PDF]

open access: yesAPMIS
ABSTRACT Special AT‐rich sequence‐binding protein 2 (SATB2) can distinguish primary ovarian mucinous tumors from ovarian metastases of colorectal or appendiceal tumors. However, its expression in other gynecological localizations remains underexplored.
Amaamri-Seebach T   +4 more
europepmc   +2 more sources

A 5‐marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma

open access: yesHistopathology, Volume 88, Issue 2, Page 402-413, January 2026.
An immunohistochemical panel that provides accurate distinction of ovarian mucinous tumours from metastatic pancreatic adenocarcinoma. Aims Metastatic pancreatic adenocarcinoma (PDAC), albeit uncommon, may involve the ovary, and distinction from primary ovarian mucinous tumours (OMT) poses a diagnostic challenge.
Astrid De Boeck   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy